MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-19-2024
Talis Biomedical Corporation Operating Income 2011-2026 | TLIS
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Talis Biomedical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.8 M | -115 M | -192 M | -91.2 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -66.8 M | -192 M | -116 M |
Quarterly Operating Income Talis Biomedical Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.58 M | -14.1 M | - | -17 M | -16.4 M | -19 M | - | -26.8 M | -27.3 M | -33 M | - | -38.4 M | -64.4 M | -60.5 M | - | -29.6 M | -10 M | -7.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -7.4 M | -64.4 M | -26.7 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-26.1 M | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.15 | -0.45 % | $ 316 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 8.22 | -0.24 % | $ 1.23 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.34 | 2.12 % | $ 162 M |  France |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 73.09 | -0.84 % | $ 3.99 B |  Britain |
 |
LENSAR
LNSR
|
-24.6 M | $ 6.08 | 3.4 % | $ 72.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
-244 M | $ 2.31 | 0.05 % | $ 50.9 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.46 | -3.15 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 18.22 | -1.54 % | $ 427 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 11.34 | 0.94 % | $ 406 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.01 | 1.5 % | $ 17.1 M | USA |
 |
Profound Medical Corp.
PROF
|
-41.3 M | $ 6.9 | -0.36 % | $ 209 M | Canada |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.66 | -3.43 % | $ 541 M | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.54 | -0.32 % | $ 62.7 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 38.7 | 2.35 % | $ 327 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.92 | 1.56 % | $ 38.5 M | USA |
 |
Butterfly Network
BFLY
|
-86.4 M | $ 4.45 | 1.14 % | $ 1.1 B | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.14 | -3.32 % | $ 5.94 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 10.35 | -14.81 % | $ 410 M |  Curacao |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 84.19 | 0.21 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 154.41 | -1.39 % | $ 10.9 B | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 67.16 | -1.24 % | $ 2.28 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.3 | -1.96 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 43.77 | -0.86 % | $ 1.29 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 89.58 | -2.02 % | $ 3.11 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 82.51 | -0.58 % | $ 48.3 B | USA |